Reuters logo
a month ago
BRIEF-Gensight Biologics launches capital increase of around 20 million euros
June 22, 2017 / 4:47 PM / a month ago

BRIEF-Gensight Biologics launches capital increase of around 20 million euros

1 Min Read

June 22 (Reuters) - GENSIGHT BIOLOGICS SA:

* Launches Capital Increase of Around Eur 20 Million

* FUNDS TO BE ALLOCATED TO THE PREPARATION OF THE LAUNCH OF GS010 IN EUROPE AND THE UNITED STATES

* Capital Increase Is Reserved for a Category of Persons

* FUND RAISED WOULD RESULT IN THE ISSUE OF A MAXIMUM OF APPROXIMATELY 3,908,090 NEW SHARES

* PAR VALUE OF € 0.025 PER SHARE REPRESENTING APPROXIMATELY 20% OF THE COMPANY'S SHARE CAPITAL ON AN UNDILUTED BASIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below